Study title: A study of clobazam as monotherapy for the treatment of epilepsy in children - HOECHST-ROUSSEL Canada Inc - 26/07/1996
Type of medicine: Medicines containing chemical active substances | |||||
Therapeutic area: Nervous System Diseases | |||||
Brands: Please see report | |||||
MAH holders: Please see report, Please see report, Please see report | |||||
Assessment: | |||||
Active substance: CLOBAZAM | |||||
ATC code: N05BA09 | |||||
Document link: | |||||
Document date: 2011-09-15 | |||||
Study number: HR376/8/CDN/301/EP | |||||
EudraCT number: | |||||
Scope of study: Clinical | |||||
Population of study subjects: | Preterm newborn Infants | Newborn infants (1 to 27 days) | Infants and toddlers (28 days to 24 months) | Children (2 to 11 years) | Adolescents (12 to 18 years) |
- | - | Y | Y | Y |